Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04005690
Title Cobimetinib or Olaparib in Treating Patients With Resectable Pancreatic Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors OHSU Knight Cancer Institute
Indications

pancreatic adenocarcinoma

Therapies

Olaparib

Cobimetinib

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.